Evidence Associated with the Use of Oxazolidinones in the Treatment of Skin and Skin Structure Infections: A Retrospective Study

Autor: Tiago Santos, Rui Carvalho, Miguel Araújo Abreu, Ernestina Reis, André Couto de Carvalho

Publikováno v: Acta Médica Portuguesa, Vol 33, Iss 2 (2020)

N/a.

Externí odkaz: https://doaj.org/article/3b09a9cd87f0400691b33aec0abf7790

Evidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study

Autor: João Gonçalves-Pereira, Filipe Froes, Fernanda Paula Santos, Helena Sofia Antão, João Paulo Guimarães

Publikováno v: Acta Médica Portuguesa, Vol 32, Iss 6 (2019)

Introduction: Skin and skin structure infections are an increasing cause of hospitalization. Although mortality is relatively low, skin and skin structure infections are associated with prolonged hospital length of stay and high costs. Oxazolidinones

Externí odkaz: https://doaj.org/article/3e783a947ec9460aaa8d4b5f3d1acb78

Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial

Autor: Mia M. Pries-Heje, Christoffer Wiingaard, Nikolaj Ihlemann, Sabine U. Gill, Niels E. Bruun, Hanne Elming, Jonas A. Povlsen, Trine Madsen, Kaare T. Jensen, Kurt Fursted, Martin Schultz, Lauge Østergaard, Jens J. Christensen, Ulrik Christiansen, Flemming Rosenvinge, Jannik Helweg-Larsen, Emil L. Fosbøl, Lars Køber, Christian Torp-Pedersen, Niels Tønder, Claus Moser, Kasper Iversen, Henning Bundgaard

Publikováno v: Pries-Heje, M M, Wiingaard, C, Ihlemann, N, Gill, S U, Bruun, N E, Elming, H, Povlsen, J A, Madsen, T, Jensen, K T, Fursted, K, Schultz, M, Østergaard, L, Christensen, J J, Christiansen, U, Rosenvinge, F, Helweg-Larsen, J, Fosbøl, E L, Køber, L, Torp-Pedersen, C, Tønder, N, Moser, C, Iversen, K & Bundgaard, H 2022, ' Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial ', The New England Journal of Medicine, vol. 386, no. 6, pp. 601-602 . https://doi.org/10.1056/NEJMc2114046
Pries-Heje, M M, Wiingaard, C, Ihlemann, N, Gill, S U, Bruun, N E, Elming, H, Povlsen, J A, Madsen, T, Jensen, K T, Fursted, K, Schultz, M, Østergaard, L, Christensen, J J, Christiansen, U, Rosenvinge, F, Helweg-Larsen, J, Fosbøl, E L, Køber, L, Torp-Pedersen, C, Tønder, N, Moser, C, Iversen, K & Bundgaard, H 2022, ' Five-year outcomes of the Partial oral Treatment of endocarditis (POET) trial ', New England Journal of Medicine, vol. 386, no. 6, pp. 601-602 . https://doi.org/10.1056/NEJMc2114046

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc975377a4eca0b3afca1f41c11796b2
https://pubmed.ncbi.nlm.nih.gov/35139280

Evidência Associada ao Uso de Oxazolidinonas no Tratamento de Infecções da Pele e das Estruturas da Pele: Estudo Retrospectivo

Autor: Ernestina Reis, Miguel Araújo Abreu, Rui A. Carvalho, Tiago Santos, André Couto de Carvalho

Publikováno v: Acta Médica Portuguesa, Vol 33, Iss 2, Pp 150-150 (2020)
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

Submitted by José Pereira (jro.pereira@gmail.com) on 2021-06-11T11:34:02Z No. of bitstreams: 1 Evidence Associated with the Use of Oxazolidinones.pdf: 132566 bytes, checksum: ea115639e273b679042b0fc2b70e2d50 (MD5) Made available in DSpace on 2021-06

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4571bdcd1b9d82787b37148bbd90a33f
https://pubmed.ncbi.nlm.nih.gov/31292027

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

Autor: Christian Torp-Pedersen, Emil L Fosbøll, Lars Køber, Claus Moser, Jens Jørgen Christensen, Kurt Fursted, Henrik Carl Schønheyder, Sabine Gill, Christine Falk Klein, Dan Eik Høfsten, Hanne Elming, Kaare T. Jensen, Jannik Helweg-Larsen, Nikolaj Ihlemann, Henning Bundgaard, Trine Madsen, F. S. Rosenvinge, Niels Tønder, Niels Eske Bruun, Martin Schultz, Kasper Iversen

Publikováno v: Iversen, K, Ihlemann, N, Gill, S U, Madsen, T, Elming, H, Jensen, K T, Bruun, N E, Høfsten, D E, Fursted, K, Christensen, J J, Schultz, M, Klein, C F, Fosbøll, E L, Rosenvinge, F, Schønheyder, H C, Køber, L, Torp-Pedersen, C T, Helweg-Larsen, J, Tønder, N, Moser, C & Bundgaard, H 2019, ' Partial oral versus intravenous antibiotic treatment of endocarditis ', New England Journal of Medicine, vol. 380, no. 5, pp. 415-424 . https://doi.org/10.1056/NEJMoa1808312
Iversen, K, Ihlemann, N, Gill, S U, Madsen, T, Elming, H, Jensen, K T, Bruun, N E, Høfsten, D E, Fursted, K, Christensen, J J, Schultz, M, Klein, C F, Fosbøll, E L, Rosenvinge, F, Schønheyder, H C, Køber, L, Torp-Pedersen, C, Helweg-Larsen, J, Tønder, N, Moser, C & Bundgaard, H 2019, ' Partial oral versus intravenous antibiotic treatment of endocarditis ', The New England Journal of Medicine, vol. 380, no. 5, pp. 415-424 . https://doi.org/10.1056/NEJMoa1808312
Iversen, K, Ihlemann, N, Gill, S U, Madsen, T, Elming, H, Jensen, K T, Bruun, N E, Høfsten, D E, Fursted, K, Christensen, J J, Schultz, M, Klein, C F, Fosbøll, E L, Rosenvinge, F, Schønheyder, H C, Køber, L, Torp Pedersen, C, Helweg Larsen, J, Tønder, N, Moser, C & Bundgaard, H 2019, ' Partial oral versus intravenous antibiotic treatment of endocarditis ', New England Journal of Medicine, vol. 380, no. 5, pp. 415-424 . https://doi.org/10.1056/NEJMoa1808312

Background Patients with infective endocarditis on the left side of the heart are typically treated with intravenous antibiotic agents for up to 6 weeks. Whether a shift from intravenous to oral antibiotics once the patient is in stable condition wou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a4dfc88ae05caf8c933038226abf93f
https://doi.org/10.1056/nejmoa1808312